Top Banner
Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London School Hygiene Tropical Medicine Biomedical Research & Training Institute, Harare
23

Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Mar 27, 2015

Download

Documents

Katelyn Griffin
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Intensified TB case-finding: still wide open to questions and answers

Dr Liz Corbett

Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London School Hygiene Tropical

Medicine

Biomedical Research & Training Institute, Harare

Page 2: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Pre-DOTS era

ICF widely used in all continents– Mass mini-radiographs and household enquiries

– Diagnosis and treatment +/- sanatoria

– Still used in some settings today

Use associated with declining TB incidence rates in

many settings

Not formally evaluated as an isolated intervention

Page 3: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Kolin

1961 – 1972 Kolin study– 5 rounds of MMR

– Point prevalence of s+ TB fell from 233 to 56 per 100k

– Incidence of s+ TB fell from 142 to 52 per 100k per year

– Effective TB treatment introduced + BCG

72% of all cases detected between MMR rounds through

passive CFT

More effective to focus on effective treatment of cases

presenting passively

Page 4: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

India

Tumkur District prevalence survey 1960s (TST and CXR)– No TB treatment programme

Follow-up investigation for symptoms (?delay)– 70% of smear-positive patients aware of symptoms

– 50% had already sought care

Bangalore– CXR versus CXR plus symptom screen

• Symptoms added little to CXR• Symptoms alone identified 70% culture-positive TB patients

Banerji D, Anderson S. A sociological study of awareness of symptoms among persons with pulmonary tuberculosis. Bull Wld Hlth Org 1963; 29:665-683.Gothi GD, et al. Estimation of prevalence of bacillary tuberculosis on basis of chest x-ray and-or symptomatic screening. Indian J Med Res 1976; 64(8):1150-1159.

Page 5: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Kenya

Case-finding studies in 1970s and 1980s– House-to-house surveys most effective

• 80% of cases had been to clinic with symptoms• Distance to clinic

– Interview of village elders ineffective

– Mothers asked to refer anyone with symptoms in their household

• High yield in those who attended• Low population impact (4% all cases)

Page 6: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Korea

Routine use of “school leavers” for door-to-door enquiry– Each employee covered 10,000 pop

– Over 50% of cases picked up this way during 1970s

Page 7: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

0%

5%

10%

15%

20%

25%

30%

1954 1957 1960 1963 1966 1969 1972

500

1,000

1,500

2,000

2,500

3,000ARITB incidence

Passive & intensified CFT &

BCG

INH RCT:

42% pop INH

12mos

INH all residents

Community-wide preventive therapy: Bethel ARI (%) & incidence rates / 100 000 pop p.a.

Page 8: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Other studies

Toman (1976)– 75% of cases self-presenting in countries covered by MMR

programmes

– Netherlands – annual CXR (2.5 million adults) • 15% of s+ and 25% of c+ TB detected through MMR

– Expensive, not cost-effective

– Assumes equal public health impact of ACF & PCF pick-up

Toman K. Mass radiography in tuberculosis-control. Who Chronicle 1976; 30(2):51-57

Page 9: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Fate of pulmonary TB treated under routine conditions

High rates of treatment failure and recurrence

Increasing recognition of the importance of adequate

treatment

First priorities:– Effective diagnosis in patients presenting passively

– Effective treatment of those presenting passively

– Don’t waste money and risk overwhelming health systems with ICF until these basics are in place DOTS

Page 10: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

ICF in the DOTS era

Low case-detection a major factor limiting TB control– Patients with symptoms cannot access investigations– Marginalised populations– Not all TB is highly symptomatic

HIV-associated TB – Driving up global incidence rates – High prevalence of active TB in HIV care settings– High mortality rates

Modeling the impact of better case-finding

Time ripe to reconsider ICF

Page 11: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

ICF goals

Reduce morbidity and mortality– More intensive case-finding leads to fewer TB deaths and

less severe post-TB complications– Focus on those most at risk of severe morbidity

Reduce TB transmission– General community– Institutional settings– Marginalised populations

Increase case-finding– Target high risk groups– Community-wide approach

Page 12: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

ICF challenges

Poor treatment outcomes– Patients detected through ICF unwilling to be treated

– ICF in settings of high primary MDR-TB

Diagnostic approach– Active versus inactive TB

– Relatively low % smear-positive cases• Choice of screening and diagnostic tests

– Illnesses other than TB• OIs & HIV itself

Overwhelm the health system

Page 13: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Cohort study Prevalence studysnap shot in time

Time (person years)

Incidence and prevalence linked by duration of disease

Page 14: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Prevalent TB disease

High ratio of prevalent: incident disease among HIV-ves– See next slide

Risk groups for prevalent TB disease– Household contacts– Homeless– IDU– VCT attenders– Home based care– Congregate settings: prisons and miners– Old age and male sex

Page 15: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Prevalence: incidence

Case notification rate Point prevalence Ratio2000 China 17 72 4.21997 Philippines 118 229 1.91995 Korea 26 60 2.32004 Harare 441 129 0.3

Harare: symptomatic 21 0.05

Page 16: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Can have prolonged HIV/TB with minimal symptoms: duration of smr+ before diagnosis

+ve Incident 620 Undetermined ‡ 1994 No+ve Incident 272 Undetermined ‡ No No+ve Prevalent 241 292 No Yes**+ve Incident 148 266 No No+ve Incident 53 97 No No+ve Incident 42 89 No No+ve Incident 39 Undetermined †† No No+ve Incident 31 Undetermined †† No No+ve Incident 29 99 No No-ve Incident 26 Undetermined ‡ No No+ve Incident 23 99 No No+ve Incident 9 50 No No+ve Incident 1 71 No No

Isoniazid preventive

therapy

HIV status

Incident or

prevalent TB case

Min. duration of positive smear

(days)*

Max. possible duration of

smear positivity (days)†

Previous TB

treatment

Page 17: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

What do we need to know?

ICF in high HIV prevalence populations– Screening algorithms

• Expect these to vary by HIV status• Expect these to vary by effectiveness of DOTS

– Can ICF substantially improve TB control?

ICF and treatment outcomes– High and low MDR-TB settings– IDU

Better understanding of prevalent TB disease– Impact of HIV– Why is prevalent TB so common in HIV-ve pops?– Does IPT increase risk of prolonged TB excretion

Page 18: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

What do we need to know?

Targeted ICF: how to do it better– Strategies to reach high risk populations (Tables1 & 2)

• High risk of TB morbidity• High risk of prevalent active TB

– Strategies accessible by the general population• ZAMSTAR• TB screening clinics akin to VCT clinics• TB screening clinics accessible only on referral

– Involving the community• TB clubs / shop keepers / home based care

– Linked to better management of smear-negative TB

Page 19: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Institutional TB

How much TB is institutionally acquired?– TST conversion in student nurses

• 18% p.a. strict US criteria after negative 2-step in Harare– Will have parallel ELISPOT data

• ? 10+% annual risk of TB disease if HIV+ve

– HIV care patients• Recurrent TB disease in patients on ARVs• Gold miners:

– recurrent TB increased from ~8% p.a to ~25% p.a. in HIV+– Coincided with introduction of HIV care clinic

Can ICF control institutional TB transmission?– Long term preventive therapy?– Role of culture-based ICF

Page 20: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Ongoing research

Shop keepers: Malawi

ZAMSTAR

DETECTB

Cambodia

Kenya

Others?

Institutional TB: ARTI in student nurses– Others?

Page 21: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Recommended priority groups for targeted ICF

VCT clients

HIV care clinics

Patients starting ARVs (IRIS)

Household contacts

IVDU

Institutions– Prisons

– hospitals

Page 22: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

General population screening

Insufficient evidence on which to base recommendations– Potential HUGE: true TB prevention– Impact of a single round or brief period of highly effective

population-based ICF?• DOTS can be the sustainable element (Bethel0• One passive = one ICF patient?• Respective roles of reactivation and recent TB infection

Effective screening tool: digital MMR??

Effective diagnostic test

Effective case-management– Note that in high HIV prevalence settings the ratio of prevalent to

incident cases may not be all that high– Would expect a rapid impact on new TB cases if prevalent TB

disease control is improved

Page 23: Intensified TB case-finding: still wide open to questions and answers Dr Liz Corbett Bloomsbury Wellcome Trust Centre & Clinical Research Unit, London.

Conclusions

ICF is natural extension of DOTS – Operational research priorities & interim recommendations – p 7– Targeted linked to IPT and ARVS

• VCT clients• Institutional TB control• Household contact screening• IDUs

– General populations: model / demonstration programmes?• TB screening clinics• Shop-keepers • ZAMSTAR approach• Household screening• MMRs

TB case-finding is HIV case finding– Chronic cough patients in Harare

• HIV prevalence 83% overall: 88% in TB patients